These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 19702114

  • 1. [Vascular inflammation: effect of proatherogenic dyslipidemic trio or quartet].
    Zamaklar M, Lalić K, Lalić N.
    Med Pregl; 2009; 62 Suppl 3():37-42. PubMed ID: 19702114
    [Abstract] [Full Text] [Related]

  • 2. [Dyslipidemia and atherosclerosis].
    Koba S, Hirano T.
    Nihon Rinsho; 2011 Jan; 69(1):138-43. PubMed ID: 21226274
    [Abstract] [Full Text] [Related]

  • 3. Increased PAFAH and oxidized lipids are associated with inflammation and atherosclerosis in hypercholesterolemic pigs.
    De Keyzer D, Karabina SA, Wei W, Geeraert B, Stengel D, Marsillach J, Camps J, Holvoet P, Ninio E.
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2041-6. PubMed ID: 19797705
    [Abstract] [Full Text] [Related]

  • 4. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
    Kontush A, Chapman MJ.
    Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
    [Abstract] [Full Text] [Related]

  • 5. Reverse cholesterol transport and atherosclerosis. A mini review.
    Cucuianu M, Coca M, Hâncu N.
    Rom J Intern Med; 2007 Sep; 45(1):17-27. PubMed ID: 17966439
    [Abstract] [Full Text] [Related]

  • 6. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M.
    Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932
    [Abstract] [Full Text] [Related]

  • 7. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia.
    Duarte MM, Rocha JB, Moresco RN, Duarte T, Da Cruz IB, Loro VL, Schetinger MR.
    Clin Biochem; 2009 May; 42(7-8):666-71. PubMed ID: 19318029
    [Abstract] [Full Text] [Related]

  • 8. The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol.
    Nicholls S, Lundman P.
    Semin Vasc Med; 2004 May; 4(2):187-95. PubMed ID: 15478040
    [Abstract] [Full Text] [Related]

  • 9. The predictive role of atherogenic dyslipidemia in subjects with non-coronary atherosclerosis.
    Berneis K, Rizzo M, Spinas GA, Di Lorenzo G, Di Fede G, Pepe I, Pernice V, Rini GB.
    Clin Chim Acta; 2009 Aug; 406(1-2):36-40. PubMed ID: 19433079
    [Abstract] [Full Text] [Related]

  • 10. [Thyroid diseases, dyslipidemia and cardiovascular risk].
    Jiskra J, Límanová Z, Antosová M.
    Vnitr Lek; 2007 Apr; 53(4):382-5. PubMed ID: 17578170
    [Abstract] [Full Text] [Related]

  • 11. Role of oxidative modifications in atherosclerosis.
    Stocker R, Keaney JF.
    Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655
    [Abstract] [Full Text] [Related]

  • 12. Antiatherogenic small, dense HDL--guardian angel of the arterial wall?
    Kontush A, Chapman MJ.
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):144-53. PubMed ID: 16505860
    [Abstract] [Full Text] [Related]

  • 13. Homocysteine increases the risk associated with hyperlipidaemia.
    Daly C, Fitzgerald AP, O'Callaghan P, Collins P, Cooney MT, Graham IM, COMAC Group.
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
    [Abstract] [Full Text] [Related]

  • 14. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
    Nordestgaard BG, Zacho J.
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
    [Abstract] [Full Text] [Related]

  • 15. [The role of infection and inflammation in the pathogenesis of atherosclerosis].
    Jaber J, Murín J, Kinová S, Gavorník P, Ghanem Wisam MA, Radman A, Gharaibeh A, Richter P.
    Vnitr Lek; 2002 Jul; 48(7):657-66. PubMed ID: 12197410
    [Abstract] [Full Text] [Related]

  • 16. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
    Andican G, Seven A, Uncu M, Cantaşdemir M, Numan F, Burçak G.
    Scand J Clin Lab Invest; 2008 Jul; 68(6):473-8. PubMed ID: 18609113
    [Abstract] [Full Text] [Related]

  • 17. [Lipids and atherosclerosis].
    Gmiński J.
    Wiad Lek; 1996 Jul; 49(7-12):153-8. PubMed ID: 9245111
    [Abstract] [Full Text] [Related]

  • 18. Atherogenic dyslipidemia and oxidative stress: a new look.
    Rizzo M, Kotur-Stevuljevic J, Berneis K, Spinas G, Rini GB, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Vekic J.
    Transl Res; 2009 May; 153(5):217-23. PubMed ID: 19375682
    [Abstract] [Full Text] [Related]

  • 19. The significance of low-density-lipoproteins size in vascular diseases.
    Rizzo M, Berneis K, Corrado E, Novo S.
    Int Angiol; 2006 Mar; 25(1):4-9. PubMed ID: 16520717
    [Abstract] [Full Text] [Related]

  • 20. The double jeopardy of HDL.
    Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Hama S, Hough G, Bachini E, Grijalva VR, Wagner AC, Shaposhnik Z, Fogelman AM.
    Ann Med; 2005 Mar; 37(3):173-8. PubMed ID: 16019715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.